Mustang Bio

Mustang BioMustang Bio
Mustang Bio

Mustang Bio

Clinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.

Website
2017Active43Worcester, United States
Rate
Advertise here

About

Mustang Bio is a clinical-stage biopharmaceutical company focused on developing and commercializing gene therapies for patients suffering from rare genetic diseases. Their approach involves using lentiviral gene therapy to deliver functional genes to target cells, aiming to correct the underlying cause of diseases like X-linked severe combined immunodeficiency (X-SCID) and Fanconi anemia (FA).

Technology stack

detected 2026-07-11
Email
Hosting
self_managed
Stack
Analytics
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Mustang Bio do?

Mustang Bio is a clinical-stage biopharmaceutical company focused on developing and commercializing gene therapies for patients suffering from rare genetic diseases. Their approach involves using lentiviral gene therapy to deliver functional genes to target cells, aiming to correct the underlying cause of diseases like X-linked severe combined immunodeficiency (X-SCID) and Fanconi anemia (FA).

Where is Mustang Bio headquartered?

Mustang Bio is headquartered in Worcester, United States.

When was Mustang Bio founded?

Mustang Bio was founded in 2017.

What industry does Mustang Bio operate in?

Mustang Bio operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials.

How many employees does Mustang Bio have?

Mustang Bio has approximately 43 people on record.

What is Mustang Bio's revenue?

StartupHub estimates Mustang Bio's annual revenue at $2.9M (range $1.6M to $5.1M, 64% confidence), based on comparable companies in the sector.